Short-term corticosteroids and avascular necrosis: Medical and legal realities

Cutis

Volumn 80, Issue 4, 2007, Pages 343-348

  Richards, Robert N ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; PREDNISONE;

ARTICLE; BONE NECROSIS; CHEMICALLY INDUCED DISORDER; DRUG ADMINISTRATION; HUMAN; MALPRACTICE;

DRUG ADMINISTRATION SCHEDULE; GLUCOCORTICOIDS; HUMANS; MALPRACTICE; OSTEONECROSIS; PREDNISONE;

EID: 38849118542     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Bialas MC, Routledge PA. Adverse effects of corticosteroids. Adverse Drug React Toxicol Rev. 1998;17:227-235.
2. Buchman AL. Side effects of corticosteroid therapy. J Clin Gastroenterol. 2001;33:289-294.
3. Lester RS, Knowles SR, Shear NH. The risks of systemic corticosteroid use. Dermatol Clin. 1998;16: 277-288.
4. Gallant C, Kenny P. Oral glucocorticoids and their complications: a review. J Am Acad Dermatol. 1986;14: 161-177.
5. Williams LC, Nesbitt LT. Update on systemic glucocorticosteroids in dermatology. Dermatol Clin. 2001;19: 63-77.
6. Nesbitt LT. Minimizing complications from systemic glucocorticosteroid use. Dermatol Clin. 1995;13: 925-939.
7. Kasper DL, Braunwald E, Fauci AS, et al, eds. Harrison's Principles of Internal Medicine. 16th ed. New York, NY: McGraw-Hill; 2005.
8. Murray JF, Nadel JA, ed. Textbook of Respiratory Medicine. Philadelphia, Pa: WB Saunders Co; 2000.
9. Nesbitt LT. Glucocorticosteroids. In: Bolognia JL, Jorizzo JL, Rapini RP, eds. Dermatology. London, England: Mosby; 2003:1979-1989.
10. Wolverton SE. Systemic corticosteroids. In: Wolverton SE, ed. Comprehensive Dermatologic Drug Therapy. Philadelphia, Pa: WB Saunders Co; 2001: 109-146.
11. Schimmer BP, Parker KL. Adrenocorticotropic hormone; adrenocortical steroids and their synthetic analogs; inhibitors of the synthesis and actions of adrenocortical hormones. In: Hardman JG, Limbird LE, Gilman AG, eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 10th ed. New York, NY: McGraw-Hill; 2001:1649-1677.
12. Boumpas DT, Wilder RL. Corticosteroids. In: Koopman WJ, ed. Arthritis and Allied Conditions: A Textbook of Rheumatology. 14th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2001:827-847.
13. McKee MD, Waddell JP, Kudo PA, et al. Osteonecrosis of the femoral head in men following short-course corticosteroid therapy: a report of 15 cases. CMAJ. 2001;164: 205-206.
14. Wong GK, Poon WS, Chiu KH. Steroid-induced avascular necrosis of the hip in neurosurgical patients: epidemiological study. ANZ J Surgery. 2005;75: 409-410.
15. Assouline-Dayan Y, Chang C, Greenspan A, et al. Pathogenesis and natural history of osteonecrosis. Semin Arthritis Rheum. 2002;32:94-124.
16. Jones JP Jr. Osteonecrosis. In: Koopman WJ, ed. Arthritis and Allied Conditions: A Textbook of Rheumatology. 14th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2001: 2143-2164.
17. Lieberman JR, Berry DJ, Mont MA, et al. Osteonecrosis of the hip: management in the 21st century. Instr Course Lect. 2003;52:337-355.
18. Mont MA, Hungerford DS. Non-traumatic avascular necrosis of the femoral head. J Bone Joint Surg. 1995;77: 459-474.
19. Agarwala S, Jain D, Joshi VR, et al. Efficacy of alendronate, a bisphosphonate, in the treatment of AVN of the hip. a prospective open-label study. Rheumatology. 2005;44:352-359.
20. Kopecky KK, Braunstein EM, Brandt KD, et al. Apparent avascular necrosis of the hip: appearance and spontaneous resolution of MR findings in renal allograft recipients. Radiology. 1991;179:523-527.
21. Gebhard KL, Maibach HI. Relationship between systemic corticosteroids and osteonecrosis. Am J Clin Dermatol. 2001;2:377-388.
22. Mirzai R, Chang C, Greenspan A, et al. The pathogenesis of osteonecrosis and the relationships to corticosteroids. J Asthma. 1999;36:77-95.
23. Pietrogrande V, Mastromarino R. Osteopatia da prolungato trattamento cortisonico. Ortop Traumatol Apparat Mot. 1957;25:791-810.
24. Fisher DE, Bickel WH. Corticosteroid-induced avascular necrosis, a clinical study of seventy-seven patients. J Bone Joint Surg Am. 1971;53:859-873.
25. Freeman HJ, Freeman KJ. Prevalence rates and an evaluation of reported risk factors for osteonecrosis (avascular necrosis) in Crohn's disease. Can J Gastroenterol. 2000;14:138-143.
26. Klingenstein G, Levy RN, Kornbluth A, et al. Inflammatory bowel disease related osteonecrosis: report of a large series with a review of the literature. Aliment Pharmacol Ther. 2005;21:243-249.
27. Gladman DD, Urowitz MB, Chaudhry-Ahluwalia V, et al. Predictive factors for symptomatic osteonecrosis in patients with systemic lupus erythematosus. J Rheumatology. 2001;28:761-765.
28. Bradbury G, Benjamin J, Thompson J, et al. Avascular necrosis of bone after cardiac transplantation, prevalence and relationship to administration and dosage of steroids. J Bone Joint Surg Am. 1994;76:1385-1388.
29. Horiuchi H, Hashikura Y, Hisa K, et al. Osteonecrosis of the femoral head in Japanese adults after liver transplantation: a preliminary report. J Orthop Sci. 2004;9: 119-121.
30. Ce P, Gedizlioglu M, Gelai F, et al. Avascular necrosis of the bones: an overlooked complication of pulse steroid treatment of multiple sclerosis. Eur J Neurol. 2006;13: 857-861.
31. Wang GJ, Cui Q, Balian G. The Nicolas Andry award, the pathogenesis and prevention of steroid-induced osteonecrosis. Clin Orthop Relat Res. 2000;370: 295-310.
32. Pritchett JW. Statin therapy decreases the risk of osteone-crosis in patients receiving steroids. Clin Orthop Relat Res. 2001;386:173-178.
33. Drescher W, Weigert KP, Bünger MH, et al. Femoral head blood flow reduction and hypercoagulability under 24 h megadose steroid treatment in pigs. J Orthop Res. 2004;22:501-508.
34. Zalavras C, Shah S, Birnbaum MJ, et al. Role of apoptosis in glucocorticoid-induced osteoporosis and osteonecrosis. Crit Rev Eukaryot Gene Exp. 2003;13: 221-235.
35. Calder JD, Buttery L, Revell PA, et al. Apoptosis - a significant cause of bone cell death in osteonecrosis of the femoral head. J Bone Joint Surg (Br). 2004;86:1209-1213.
36. Anderton JM, Helm R. Multiple joint osteonecrosis following short-term steroid therapy. J Bone Joint Surg Am. 1982;64:139-141.
37. Taylor LJ. Multifocal avascular necrosis after short-term high-dose steroid therapy. J Bone Joint Surg Am. 1984;66:431-433.
38. Skinner JA, Mann BS, Carrington RW, et al. Male infertility and avascular necrosis of the femoral head. Ann R Coll Surg Engl. 2004;86:15-17.
39. Koo KH, Kim R, Kim YS, et al. Risk period for developing osteonecrosis of the femoral head in patients on steroid treatment. Clin Rheumatol. 2002;21:299-303.
40. Oinuma K, Harada Y, Nawata Y, et al. Osteonecrosis in patients with systemic lupus erythematosus develops very early after starting high dose corticosteroid treatment. Ann Rheum Dis. 2001;60:1145-1148.
41. Fisher DA. Long-term administration of therapeutic corticosteroids without risk of inducing aseptic necrosis. Int J Dermatol. 1998;37:15-17.
42. Nasser SM, Ewan PW. Depot corticosteroid treatment for hay fever causing avascular necrosis of both hips. BMJ. 2001;322:1589-1591.
43. Kubo T, Kojima A, Yamazoe S, et al. Osteonecrosis of the femoral head that developed after long-term topical steroid application. J Orthop Sci. 2001;6: 92-94.
44. Rozental TD, Sculco TP. Intra-articular corticosteroids: an updated overview. Am J Orthop. 2000;29:18-23.
45. Mistlin A, Gibson T. Osteonecrosis of the femoral head resulting from excessive corticosteroid nasal spray use. J Clin Rheumatol. 2004;10:45-47.
46. Kisielinski K, Niedhart C, Schneider U, et al. Osteonecrosis 15 years after femoral neck fracture and long-term low-dose inhaled corticosteroid therapy. Joint Bone Spine. 2004;71:237-239.
47. Lester RS. Bone complications of corticosteroids. J Cutan Med Surg. 1996;1:50-5 7.
48. Yosipovitch G, Hoon TS, Leok GC. Suggested rationale for prevention and treatment of glucocorticoid-induced bone loss in dermatologic patients. Arch Dermatol. 2001;137:477-481.
49. Summey BT, Yosipovitch G. Glucocorticoid-induced bone loss in dermatologic patients: an update. Arch Dermatol. 2006;142:82-90.
50. Crane M. The medication errors that get doctors sued. Med Econ. 1993;22:36-38, 40-41.
51. Patten SB, Neutel CI. Corticosteroid-induced adverse psychiatric effects: incidence, diagnosis, and management. Drug Safety. 2000;22:111-122.